These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 19899622)

  • 1. The cross-reactivity of Shewanella fidelis lipopolysaccharide with anti-Proteus antibodies.
    Kwinkowski M; Grabowski S; Konieczna I; Nazarenko EL; Kaca W
    Pol J Microbiol; 2009; 58(3):275-8. PubMed ID: 19899622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and serological characterization of an Nepsilon-[(R)-1-carboxyethyl]-L-lysine-containing O-chain of the lipopolysaccharide of Proteus mirabilis O13.
    Swierzko AS; Cedzyński M; Ziółkowski A; Senchenkova SN; Perepelov AV; Knirel YA; Kaca W
    Arch Immunol Ther Exp (Warsz); 2001; 49(2):163-9. PubMed ID: 11348021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of human antibodies binding with smooth and rough LPSs from Proteus mirabilis O3 strains S1959, R110, R45.
    Gleńska-Olender J; Durlik K; Konieczna I; Kowalska P; Gawęda J; Kaca W
    Antonie Van Leeuwenhoek; 2017 Nov; 110(11):1435-1443. PubMed ID: 28889208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of serological reactions of Rickettsiae-infected patients and rabbit anti-Proteus OX antibodies with Proteus OX2, OX19 and OXK lipopolysaccharides.
    Amano K; Cedzyński M; Swierzko AS; Kyohno K; Kaca W
    Arch Immunol Ther Exp (Warsz); 1996; 44(4):235-40. PubMed ID: 9017163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies Isolated from Rheumatoid Arthritis Patients against Lysine-Containing
    Durlik-Popińska K; Żarnowiec P; Lechowicz Ł; Gawęda J; Kaca W
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological characterization of the core region of lipopolysaccharides of rough Proteus sp. strains.
    Palusiak A; Sidorczyk Z
    Arch Immunol Ther Exp (Warsz); 2009; 57(4):303-10. PubMed ID: 19578814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteus mirabilis RMS 203 as a new representative of the O13 Proteus serogroup.
    Palusiak A; Siwińska M; Zabłotni A
    Acta Biochim Pol; 2015; 62(4):691-5. PubMed ID: 26645323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of an acidic O-specific polysaccharide from marine bacterium Shewanella fidelis KMM 3582T containing Nepsilon-[(S)-1-carboxyethyl]-Nalpha-(D-galacturonoyl)-L-lysine.
    Kilcoyne M; Perepelov A; Shashkov AS; Nazarenko EL; Ivanova EP; Gorshkova NM; Gorshkova RP; Savage AV
    Carbohydr Res; 2004 Jun; 339(9):1655-61. PubMed ID: 15183741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation by Proteus mirabilis negatively charged lipopolysaccharides.
    Kaca W; Literacka E; Sjöholm AG; Weintraub A
    J Endotoxin Res; 2000; 6(3):223-34. PubMed ID: 11052177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotyping of Proteus mirabilis clinical strains based on lipopolysaccharide O-polysaccharide and core oligosaccharide structures.
    Kaca W; Glenska J; Lechowicz L; Grabowski S; Brauner A; Kwinkowski M
    Biochemistry (Mosc); 2011 Jul; 76(7):851-61. PubMed ID: 21999547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of two different kinds of sera against the Proteus penneri lipopolysaccharide core region in search of epitopes determining cross-reactions with antibodies.
    Palusiak A; Dzieciatkowska M; Sidorczyk Z
    Arch Immunol Ther Exp (Warsz); 2008; 56(2):135-40. PubMed ID: 18373243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ECA-immunogenicity of Proteus mirabilis strains.
    Duda KA; Duda KT; Beczała A; Kasperkiewicz K; Radziejewska-Lebrecht J; Skurnik M
    Arch Immunol Ther Exp (Warsz); 2009; 57(2):147-51. PubMed ID: 19333729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and immunochemical studies on the lipopolysaccharide of the 'T-antigen'-containing mutant Proteus mirabilis R14/1959.
    Bartodziejska B; Radziejewska-Lebrecht J; Lipinska M; Knirel YA; Kononov LO; Chernyak AY; Mayer H; Rozalski A
    FEMS Immunol Med Microbiol; 1996 Feb; 13(2):113-21. PubMed ID: 8731019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies of epitope specificity of polyclonal antibodies against Proteus mirabilis R mutants].
    Bartodziejska B; Radziejewska-Lebrecht J; Lipińska M; Ziółkowski A; Rózalski A
    Med Dosw Mikrobiol; 1993; 45(1):99-102. PubMed ID: 7694017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and serological studies of the O-antigen of the bacterium Proteus mirabilis OXK (serogroup O3) used in the Weil-Felix test.
    Swierzko AS; Cedzynski M; Knirel YuA ; Senchenkova SN; Kocharova NA; Shashkov AS; Amano KI; Kyohno K; Kaca W
    Biochemistry (Mosc); 1997 Jan; 62(1):21-7. PubMed ID: 9113725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human anti-scrub typhus rickettsia and rabbit anti-Proteus antibodies recognize similar epitope in the O-polysaccharide part of Proteus mirabilis OXK lipopolysaccharide.
    Kaca W; Amano K; Chernyak AY; Knirel YA
    Microbios; 2000; 103(406):151-61. PubMed ID: 11131808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A total internal reflection ellipsometry and atomic force microscopy study of interactions between Proteus mirabilis lipopolysaccharides and antibodies.
    Gleńska-Olender J; Sęk S; Dworecki K; Kaca W
    Eur Biophys J; 2015 Jul; 44(5):301-7. PubMed ID: 25854960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the O-polysaccharide and serological studies of the lipopolysaccharide of Proteus penneri 60 classified into a new Proteus serogroup O70.
    Zych K; Perepelov A; Baranowska A; Zabłotni A; Shashkov AS; Knirel YA; Sidorczyk Z
    FEMS Immunol Med Microbiol; 2005 Mar; 43(3):351-6. PubMed ID: 15708308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Proteus mirabilis Antigen Immunological Complexes by Atomic Force Microscopy.
    Kaca W; Gleńska-Olender J; Konieczna I; Gawęda J; Sęk S
    Methods Mol Biol; 2019; 2021():273-283. PubMed ID: 31309512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human complement activation by smooth and rough Proteus mirabilis lipopolysaccharides.
    Kaca W; Arabski M; Fudała R; Holmström E; Sjöholm A; Weintraub A; Futoma-Kołoch B; Bugla-Płoskońska G; Doroszkiewicz W
    Arch Immunol Ther Exp (Warsz); 2009; 57(5):383-91. PubMed ID: 19707721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.